PPTMF (Perpetua Medical AB) ROCE %: -23.70% (As of Mar. 2026)


PPTMF Perpetua Medical AB PPTMF
57 GF Score
Price $1.08
GF Value $1.15
! 6 Warning Signs
View Full Analysis

What is Perpetua Medical AB ROCE %?

Perpetua Medical AB PPTMF 57 ROCE % is -23.70% as of Mar. 2026. GuruFocus rates PPTMF with a GF Score™ of 57/100 and a GF Value™ of $1.15. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Perpetua Medical AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -23.70%.

Perpetua Medical AB  (OTCPK:PPTMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Perpetua Medical AB ROCE % Related Terms

Perpetua Medical AB ROCE % Historical Data

* Premium members only.

The historical data trend for Perpetua Medical AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perpetua Medical AB ROCE % Chart

Perpetua Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.81 -99.27 -165.49 -17.72 7.72

Perpetua Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.54 -15.08 111.04 -41.38 -23.70
PPTMF
57GF Score
Perpetua Medical AB PPTMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perpetua Medical AB ROCE % Calculation

Perpetua Medical AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=0.204/( ( (1.706 - 0.304) + (4.685 - 0.799) )/ 2 )
=0.204/( (1.402+3.886)/ 2 )
=0.204/2.644
=7.72 %

Perpetua Medical AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1.128/( ( (4.685 - 0.799) + (6.33 - 0.697) )/ 2 )
=-1.128/( ( 3.886 + 5.633 )/ 2 )
=-1.128/4.7595
=-23.70 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -23.70% mean?
Perpetua Medical AB (PPTMF) has a ROCE % of -23.70% as of Mar. 2026.
Is Perpetua Medical AB's ROCE % too high?
Perpetua Medical AB's current ROCE % is -23.70%. Overall, Perpetua Medical AB has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's ROCE % compare to ABT and SYK?
Perpetua Medical AB's ROCE % of -23.70% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perpetua Medical AB's current ROCE % is -23.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Perpetua Medical AB (PPTMF) has a current ROCE % of -23.70%. The stock's GF Value™ is $1.15, compared to a current price of $1.08 — trading 6.2% below its estimated fair value. The current ROCE % is -23.70%. Perpetua Medical AB's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Perpetua Medical AB (PPTMF), the current ROCE % is -23.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perpetua Medical AB (PPTMF) Overvalued in 2026?

Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued. The current stock price of $1.08 is trading 6.2% below its estimated GF Value™ of $1.15.

Key valuation signals for PPTMF:

  • ROCE %: -23.70%
  • GF Value™: $1.15 vs. price of $1.08 (6.2% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the PPTMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perpetua Medical AB Business Description

Other Exchanges PERP B:Sweden
Address Ekeby Bruk 2H, Uppsala, SWE, SE-752 63
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
57GF Score

Get the complete analysis for PPTMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.08
Price
$1.15
GF Value